Table 1. Distribution of participants by selected variables.
*Excluding participants who took the vaccine, but the type is unknown
**Symptoms include vomiting, nausea, rashes, conjunctivitis, muscle ache, joint ache, loss of appetite/smell/taste, nose bleeding, fatigue, seizures, and other neurological symptoms
| Males (n = 65) | Females (n = 60) | Total (n = 125) | |
| Age | |||
| 14-18y | 2 | 2 | 4 |
| 19-60y | 49 | 49 | 98 |
| >60y | 14 | 9 | 23 |
| Unvaccinated | 1 | - | 1 |
| Vaccinated | 64 | 60 | 124 |
| Covaxin | 37* | 35* | 72 |
| Covishield | 24* | 23* | 47 |
| Documented positive for SARS-CoV-2 | 30 | 21 | 51 |
| Symptomatic | 13 | 8 | 21 |
| Asymptomatic | 17 | 13 | 30 |
| Symptoms | |||
| Fever | 5 | 4 | 9 |
| Sore throat | 2 | 1 | 3 |
| Cough | 3 | 1 | 4 |
| Headache | 1 | 1 | 2 |
| Others** | 1 | 2 | 3 |
| Never Diagnosed for SARS-CoV-2 | 35 | 39 | 74 |